510(k) K200129

OncoMate MSI Dx Analysis System by Promega Corporation — Product Code PZJ

K200129 is an FDA 510(k) premarket notification submitted by Promega Corporation for the device "OncoMate MSI Dx Analysis System". The FDA issued a decision of Substantially Equivalent on Jul 26, 2021. The device falls under product code PZJ (Lynch Syndrome Test System), a Class II device regulated under 21 CFR 864.1866.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Jul 26, 2021
Date Received
Jan 21, 2020
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Lynch Syndrome Test System
Device Class
Class II
Regulation Number
864.1866
Review Panel
PA
Submission Type
510(k)

The Lynch syndrome test system is used to identify loss of DNA mismatch repair proteins or microsatellite instability in tumor tissue from cancer patients for the purpose of identifying patients who may benefit from additional testing for the inherited cancer predisposition Lynch Syndrome

Need the full FDA record for Promega Corporation? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K200129. Report a data issue: hello@regdatalab.com.